Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Jim Cramer: It’s not too late to buy this portfolio health-care stock after Friday’s selloff

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. U.S. stocks jumped Monday as the Nasdaq and S & P 500 attempts to recover from back-to-back weekly losses. Major gains … Read more

The news hitting a portfolio health-care name actually removes an overhang on the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday following Tuesday’s record high close for the S & P 500 on a rebound in the … Read more

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

One down one to go — what we learned from TJX’s great quarter and hope to hear from Salesforce

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. U.S. stocks were trending lower as investors awaited important inflation data and mulled over more quarterly earnings. January’s PCE price … Read more

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month … Read more

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday on hotter-than-expected retail inflation data. The surprise uptick in the January consumer price index sent bond … Read more

Wall Street changes its tune on this healthcare stock. Why we were always bullish

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer … Read more

Portfolio health care name turns its luck around thanks to management’s AI push

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. U.S. stocks were mostly higher on Friday. The S & P 500 was on track for a fifth positive week … Read more

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. Analysts at four equity research firms boosted their price targets for GE Healthcare since the maker of … Read more

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July … Read more

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall … Read more

January was great for stocks — here are the top 5 performers in the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Benchmark gauges notched all-time highs as stocks charged through a busy earnings season. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We’re trimming a health-care stock ahead of earnings — hedging our bets on business in China

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re selling 95 shares of GE Healthcare at roughly $74. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,150 shares of GEHC, reducing its weighting to 2.75% from 2.97%. The small trim we’re making in GE Healthcare with the stock up slightly in an otherwise … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three … Read more

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the … Read more

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company’s obesity drug Zepbound. The situation seems rather clear-cut to us: It’s no reason to sell. Eli Lilly shares on Tuesday shook off afternoon losses to … Read more

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It looks like Cigna has scrapped its takeover bid for Club holding Humana , removing a dark cloud over both stocks that’s lingered since the acquisition talks surfaced nearly two weeks ago. Cigna and Humana were unable to agree on an acquisition price and other financial … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer urged Humana (HUM) not to pursue a merger with rival health insurer Cigna (CI), questioning the merits of a potential business combination and the likelihood of it passing U.S. antitrust review. Cigna and Humana could reach an agreement on a stock-and-cash transaction by the … Read more

Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Wall Street was mixed Monday after the Dow , the S & P 500 and the Nasdaq finished higher for … Read more

Amazon adds a new reason to get and keep Prime: member discounts on health-care services

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amazon (AMZN) said on Wednesday that it’s offering Prime members a discount on its new health-care service — another perk that should help bring more people into the online retailer’s ecosystem. The One Medical service, which typically costs $199 annually, will be available to Prime subscribers … Read more

The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter. Revenue for the … Read more

We had a busy week of trades in an oversold market. Here’s the day-by-day breakdown

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into oversold territory. However, that set us up to put cash to work and make four small buys as our discipline mandates. We also upgraded one of … Read more

We’re buying more of this life sciences stock after an earnings-driven decline

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock is under pressure in early trading due to uncertainty around the recovery in a key business. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

When is it OK to violate your cost basis to buy more shares of a company?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant … Read more

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical trades for earnings season. Asset allocation can be strategic or tactical. Strategic asset allocation generally refers to longer-term investing — think of this as your buy-and-hold approach. … Read more

Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the October Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their answers have been edited for clarity. 1. Why do rising interest rates have such a negative effect on technology stocks? (Rod) … Read more

Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer on Wednesday praised the incoming CEO of Walgreens Boots Alliance, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services. “This guy is the real deal. I just salute him … Read more

15 stocks with a history of dividend growth are expected to deliver once again this year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue in their current fiscal years. Long-term investors should look to own companies with a history of dividend growth instead … Read more

Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer on Squawk on the Street, June 30, 2022. Virginia Sherwood | CNBC CNBC’s Jim Cramer on Monday suggested that investors keep an eye on Vertex Pharmaceuticals (VRTX), a biotechnology company developing a drug to treat acute pain that is not an opioid. “The biggest … Read more

Here are all the portfolio moves the Club made in this week’s oversold market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE With the stock market deeply oversold this week, we put cash to work by picking stocks across a range of sectors including energy, technology and materials. We also added a former Club chipmaker to our Bullpen and upgraded a premium beer name to a buy rating. … Read more

We’re booking some profits on this health insurance stock after waiting out its slump

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

It’s time to get bullish on this health tech name, now that it’s shed a drag on growth

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We care much more about where a stock is going than where it’s been. With the spin-off of Veralto (VLTO) complete, we decided to look at the path ahead for Danaher (DHR) — now free of its slower-growing, lower-margin water business. In the separation , we … Read more

We’re set to receive shares in Danaher’s separated water business. Here’s our plan for the new stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Danaher (DHR) is days away from shedding its environmental-and-applied solutions segment, and the Club holding’s ability to deliver returns for shareholders appears stronger than ever. Those potential returns can come from two places: Danaher stock and shares of Veralto (VLTO), the soon-to-be-standalone company that’s in the … Read more

Health care has had a tough year. Where we stand on our 5 stocks in the sector

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been a challenging period for the industry overall. Of the 11 market sectors year to date, health care … Read more

Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buy

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here are the risks to alcohol and food stocks from Ozempic-like weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The rise of new anti-obesity medications could result in less alcohol consumption, impacting Club name Constellation Brands (STZ). The risk already seems to be playing out in food stocks with exposure to snacks and junk food. However, if necessary, the Mexican beer powerhouse behind Corona, Modelo … Read more

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this month, and our plan is to remain invested in the soon-to-be standalone company, known as Veralto, which will trade under the ticker symbol VLTO. That expectation was reinforced Wednesday when Veralto … Read more

Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

Here are the 8 trades and 3 price-target changes we made during a busy week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly results Wednesday evening and Federal Reserve Chairman Jerome Powell’s Jackson Hole address Friday. Here’s a day-by-day look at the trades and price-target changes, and what motivated each decision. Monday Monday proved … Read more

3 things point to better times ahead for this maker of X-Ray and MRI machines

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Wall Street saw some volatility Friday around Federal Reserve Chairman Jerome Powell’s morning speech from the central bank conference in … Read more

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer … Read more

We’re buying more of 2 stocks, deploying some of our cash pile in an oversold market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re putting a little more of our big cash position to work Monday into the oversold market. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here’s a rapid-fire update on all 36 stocks in the Club’s portfolio, including 2 recent buys

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the Investing Club’s August Monthly Meeting, Jim Cramer provided his latest thinking on all 36 names in his Charitable Trust. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings … Read more

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the latest regulatory filings from influential Wall Street pros. These big-name investors also made moves in nine other Club stocks during a strong three-month stretch that ended the best first half … Read more

Eli Lilly gets a new price target after a big rally. Should I buy more shares?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about … Read more

We’re optimistic about this struggling entertainment stock despite an expected weak quarter

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Back-to-back losses Still believe in Disney Eli Lilly keeps going 1. Back-to-back losses U.S. stocks on Wednesday were sinking for the … Read more

Here’s what is behind the stock market’s selloff and what we’re doing about it

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli Lilly surges Palo Alto slumps 1. Stocks sink U.S. stocks tumbled Tuesday after Moody’s downgraded the credit rating … Read more

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. … Read more

Troubled health name bounces after strong quarter and guidance. Here’s our view on the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Troubled Club holding Bausch Health Companies (BHC) reported better-than-expected quarterly results before the bell Thursday. However, it’s not nearly enough to get this stock out of the penalty box. Sales in the second quarter rose 10% to $2.17 billion, exceeding expectations of $2.04 billion, according to … Read more

Humana calms Wall Street’s jitters with quarterly results, clearing way for stock to run higher

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Revenue for the three months ended June 30 rose 13% year-over-year, to $26.75 billion, exceeding analysts’ estimates … Read more

We’re exiting a health-care name — putting us on the hunt to buy a new stock for the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re taking a hard look at the Bullpen and the rest of the market for new opportunities. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Why Cramer Thinks This Retailer Is the ‘Ultimate Downward Trading Play’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Health care at the center of ‘Ultimate trade-down play’ View Bullpen 1 Health care at the center Club holdings Danaher ( … Read more

Here’s what Jim Cramer thinks about J&J stock after the key ruling in the talc case

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A closely watched talc trial in California is going against Johnson & Johnson ( JNJ ), raising uncertainty over whether tens of thousands of other plaintiffs suing the company will sign on to J&J’s proposed $8.9 billion settlement offer or bide their days in court. Jim … Read more

Ford dividend quality, J&J split-off, cost discipline – what we think about it all

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Send your questions directly to Jim Cramer and his team of analysts at investingclubmailbag@cnbc.com. A reminder, we cannot provide personal investment advice. We will only consider more general questions about the investment process or the stocks in the portfolio or related industries. Question 1: What is … Read more

J&J’s strong quarter boosted by new details about its large stake in Kenvue’s consumer unit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson ( JNJ ) reported strong second-quarter earnings and revenue ahead of the opening bell on Thursday, with better-than-expected results both domestically and internationally and across all major operating segments. J & J’s sales rose 6.3% year-over-year to $25.53 billion in the second quarter, … Read more

So we are bullish on this mega-cap stock and cautious on this healthcare name

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Earnings and Inflation See J & J Upbeat Outlook for Meta 1 Earnings and Inflation US stocks rose on Monday, with … Read more

CEOs do matter when picking stocks. 5 things we look for in a leader and examples from our portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s not unusual for a company’s stock price to soar — or sink — on news of a CEO shakeup. When Mary Dillon, revered on Wall Street for her eight-year run at Ulta Beauty (ULTA), was named to the top job at Foot Locker (FL) last … Read more

These 3 stocks are struggling, but I’m not ready to give up

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE If you had told me that club names Estee Lauder ( EL ) or Danaher ( DHR ) would ever miss their spots not once, but twice, I would have told you to get your head checked. These are companies that create and drive, which is … Read more

Investing Club meeting recap: Profit on bookings remains prudent as Wall Street rallies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Big Winners Book Profits Emerson Captures Rise Humane Shares Stabilize 1 Wall Street’s big winners book profits rose Thursday, led by … Read more

Cramer Says He’ll Buy This Leading Medical Tech Stock—Wish He Could Buy Stocks Too

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Shares of GE Healthcare ( GEHC ) are falling on Thursday, giving club members a chance to invest in the medical technology company at an increasingly attractive price. Sellers are making a mistake on Thursday and we would be taking advantage of their misjudgment if it … Read more

We are opening a new position at one of the big three medical imaging and diagnostics companies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This company operates in an addressable market worth $84 billion, which is expected to grow to approximately $100 billion by 2024. MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Johnson & Johnson’s consumer health unit Kenvue has started trading. What this means for J&J shareholders like us

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson’s ( JNJ ) consumer health unit Kenvue ( KVUE ) jumped more than 22% in its first day of trading Thursday, putting the Club holding company one step closer to finalizing its business separation. The planned split, which is slated for later this … Read more

J&J’s 2025 drug sales forecast shouldn’t shake investors. So much else is similar

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Before the bell on Tuesday, Johnson & Johnson ( JNJ ) reported a strong first quarter, with sales up more than 5.5% and profit up year-over-year. Shares of the Dow component and Club holding should not lose 2.5% on such results. J&J’s first-quarter sales of $24.75 … Read more

Club meeting recap: Jim Cramer says Johnson & Johnson’s post-earnings sell-off is a mistake and a buying opportunity

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow Falls, Profits in Focus J & J Declines Missed Starbucks Undervalued? 1. Dow falls with earnings taking center stage Stocks … Read more

When quality stocks go on sale in the rough market, we love to go shopping. Here is our latest purchase

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE After keeping our powder dry since the end of February, we’ll be doing a little weakness shopping on Tuesday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer’s Investment Club meeting on Monday: Fed and jobs, China reopening, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Fed and Jobs Report Stick with China Stocks Reopen Watch Eli Lilly 1. Fed and Jobs Report Stocks traded higher on … Read more

Amazon, Wells Fargo, Microsoft, Nvidia make headlines. Here’s our take on the news

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Club holdings Amazon ( AMZN ) , Wells Fargo ( WFC ) and Nvidia ( NVDA ) and Microsoft ( MSFT ) are in the news on Wednesday. Here are the headlines and implications for the club’s investment thesis. Amazon Closes Healthcare Deal AMZN YTD mountain … Read more

Tuesday’s choppy stock market gives us an opportunity to add to the health stock that is appropriate for this environment

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sell-off in the market creates an opportunity to buy shares of companies that are doing well and will thus be in a recession. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer’s Investment Club Meeting Tuesday: Caterpillar, J&J, Humana

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Opportunity to buy Caterpillar Convinced of the decision to buy Johnson & Johnson Why buy before the overhang? 1. Opportunity to … Read more

Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected fourth-quarter earnings and revenue. Revenue rose nearly 10% on an underlying basis to $8.37 billion, well above estimates of $7.9 billion, according to Refinitiv. Adjusted earnings rose 6.7% to $2.87 per share, beating the consensus estimate … Read more

Eli Lilly is the best of both worlds—a recession-proof stock with great upside potential

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The year ahead is a crucial one for Eli Lilly ( LLY ) as the pharmaceutical giant looks to advance the drugs in its star lineup. Executives detailed reasons for optimism at a major industry meeting this week. “It’s another unprecedented year ahead for Lilly,” Chief … Read more

Two of our stocks are rising nicely. Here’s the news and our opinion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE While Wall Street tried to hang on to recent gains on Tuesday, we got some positive news on two Club holdings that are seeing big moves to the upside: Danaher ( DHR ) and Constellation Brands ( STZ ). DHR 1Y mountain Danaher’s 1-year stock performance … Read more

Jim Cramer’s Investment Club Meeting Thursday: Avoid Expensive Stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Avoid expensive stocks. Sticking with Danaher Still a Ford buyer 1. Avoid expensive stocks Stocks continued to slide on Thursday after … Read more

We’re buying a dip in the health insurance stock that bounced back in 2022

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Tuesday’s purchase put some of our roughly 10% cash position to work. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer’s Investment Club meeting Friday: Fed strategy, club mantra, buying opportunities

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. The Fed is not ready to stop. A reminder of the investment mantra. Looking to buy 1. Fed not ready to … Read more

Jim Cramer’s Investment Club Meeting Monday: Industry, Tech Buy, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. We like industrialists. We believe in Amazon. LLY 1 is still bullish. We like them. Industrialists. Wall Street was lower on … Read more

We add the oil stock and see 3 other names as good buys in a falling market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE On Friday, the markets are on sale again. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here’s what to watch out for as J&J prepares to split into two separate companies next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson ( JNJ ) is preparing to spin off its consumer health unit into a public company next year that will be separate from its pharmaceutical and medical technology businesses. Ahead of the split, Morgan Stanley issued a research note highlighting some of the … Read more

Jim Cramer’s Investment Club meeting on Thursday: Fed caution, retail tapering, Humana guidance

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Be cautious on Fed news We cut our position in COST Humana raises guidance 1 Be cautious on Fed news Stocks … Read more

Stocks typically rise in the year after interim dates. These club names have been big winners in previous cycles

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Strange but true: The S&P 500 has been solidly higher in the 12 months after midterm elections in every cycle since 1954, regardless of which party won or lost, according to Yardeni Research. The average one-year growth of the broad market index in the 17 post-election … Read more

New hope that China may soften on Covid is boosting our stocks, which are most closely linked to the No. 1 economy. 2 in the world

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Estee Lauder ( EL ) and other club holding companies with significant exposure to the Chinese economy jumped on Friday after news that BioNTech’s ( BNTX ) Covid vaccine will soon be available to foreign residents living in China. We are cautiously optimistic about vaccine development, … Read more

4 of our stocks are in the news. Here is the club’s view of each development

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Four of our club holdings — Costco Wholesale ( COST ), Amazon ( AMZN ), Humana ( HUM ) and Bausch Health ( BHC ) — were in the news Thursday. Here’s how we feel about the turn of events. Costco News: Costco reported sales for … Read more

2 closings of our daily session: selling in an overbought market, updates on 3 holdings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. It’s not too late to sell Quick Notes: QCOM, COST, HUM 1. It’s not too late to sell Stocks fell on … Read more

We are excited about the good quarter and the rosy outlook of the health insurance company Humana for the next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Club holding company Humana ( HUM ) reported a mixed but solid third quarter ahead of Wednesday’s open. Early optimism about 2023 also supported our bullish view on the health insurance company’s stock. Revenue rose 9% year-over-year to $22.75 billion, slightly missing estimates of $22.76 billion, … Read more

Eli Lilly’s guidance cut is related to a strong dollar, not weakening fundamentals, CEO says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly ( LLY ) CEO David Ricks on Tuesday expressed optimism about the drugmaker’s innovation plan, a sentiment he agreed with despite the club holding company’s crowded quarterly report issued earlier in the day. “The fundamentals of the business are really strong,” Ricks said in … Read more

J&J’s nearly $17 billion bid to buy the heart pump maker is about exactly why we own it

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson’s ( JNJ ) $16.6 billion deal to buy heart pump maker Abiomed ( ABMD ) will bolster its pharmaceutical and medical device business ahead of J&J’s plans to spin off its consumer division into a separate company. The acquisition of Abiomed is expected … Read more

Multiple revenue misses in one of our winners convinced us to take profit and exit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We never like to sell on a bad day. But after a dubious quarter, we decided to exit. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We’re leaving the drug stock for a nice profit and putting some of that money to work elsewhere

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued to rally on Thursday, with the Dow up nearly 400 points after a new GDP report beat expectations. Spencer Platt | Getty Images . MY NUMBER 1 … Read more

Deutsche Bank is building on Humana for the same reasons we own this big 2022 winner

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Analysts at Deutsche Bank took Humana to a buy rating, citing its “leadership in Medicare Advantage.” . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

2 conclusions of our daily meeting: We like healthcare and basic products, club names in the news

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Healthcare and Staples Lead the Market Quick Mentions: META, DIS, SBUX 1. Healthcare and Staples Lead the Market Stocks gained on … Read more

Jim Cramer says to buy Danaher stock on the dip

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer advised investors to add on Friday Danaher on its shopping lists for next week after it reports its third-quarter results. “Now you have an opportunity to buy one of the best-run companies in the world at a deep discount. I think you should … Read more

These two strategies can help you stay diversified in any stock market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Using correlation and the barbell strategy can help make trading decisions in any market. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

The drop in J&J shares after the earnings increase reflects more on performance in 2022 than results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It was a solid quarter for Johnson & Johnson, but the strong dollar is and will remain a headwind for the foreseeable future. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 takeaways from our daily session: Banks as market leaders, 3 deals and maintaining CRM

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. We like the banks here. We carry out 1 sale and 2 purchases. Don’t sell CRM to the power of 1. … Read more

3 Conclusions of our Daily Session: Wall Street Rebound, Small Buy, Review of Analyst Notes

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Investment Club holds its “morning meeting” every weekday at 10:20 a.m. ET. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We are cashing in on Friday’s market decline and adding one of our defensive stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We raised additional funds at the beginning of the week, anticipating that the growth in early October would soon die down. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 takeaways from our daily meeting: Stocks swing, oil down, obesity drugs fast

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Stocks Swing Sell High, Consider Buy Quick Notes: LLY, COST 1. Stocks Swing Stocks fluctuated on Thursday after starting the week … Read more

We short the winner near all-time highs after patiently waiting for the market to rally

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Tuesday’s small trade will be our highest sale price for the stock ever and just a few percent off the all-time high. MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We don’t have Eli Lilly exclusively for the potential treatment of Alzheimer’s disease. Still, we think Biogen’s topline data is very encouraging for Lilly. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

2 takeaways from our daily session: What’s behind the rebound and the club’s stock in the news

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Market Gets Oversold Bounce Quick Club Mentions: AAPL, LLY, EL 1. Market Gets Oversold Bounce US stocks recovered from last Wednesday’s … Read more

3 takeaways from Wednesday’s ‘Morning Briefing’ – We’re watching the Fed and firms with pricing power

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Let’s Let Our Stocks Run on Fed Day Firms with strong pricing are the winners here. Quick Mentions: CSCO, NVDA, QCOM, … Read more

We are buying more shares of two companies, taking us off the sidelines in this market decline

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE After patiently waiting for the market to pull back over the past few days, we’re nibbling on two high-quality stocks. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 takeaways from Tuesday morning’s briefing: Save money, watch Ford and don’t miss these exclusive interviews

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Now Is Not the Time to Buy Quick Mentions: F, HUM, META, CRM, AMZN Exclusive Covers 3 Club Names 1. Now … Read more

3 Takeaways From Monday’s Meeting: Market Needs A Break Up, Some Possible Buys

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. The market needs a breakthrough to the bottom. Why Jim Invests in Two-Year Treasuries Quick Mentions: JNJ, LLY, AMZN, QCOM, DHR … Read more

3 takeaways from Friday’s meeting, including how defensive plays are wins in this two-sided market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. The Market Is Bifurcating Quick Hits: AMZN, PG, DHR, AAPL Club Events to Watch Next Week 1. The Market Is Bifurcating … Read more

Danaher’s decision to split its water company is a win for long-term investors

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The medical diagnostics and health technology company has a strong track record of creating shareholder value through organic investments and mergers and acquisitions. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here’s how we’re positioned in the four sectors and some stocks we like in each

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer advised investors on how to build a strong portfolio amid the Federal Reserve’s fight to reduce inflation. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We’re holding a small sale in a rare move ahead of an investor event – here’s why

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We will see a small gain during a period when the S&P 500 is down more than 10%. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

How Big Tech is Doing Healthcare – We Sort Out the Strategies of Our 4 Core Holdings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE All are vying for a share of the more than $4 trillion Americans spend on their health each year. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

2 takeaways from the Investing Club ‘morning meeting’ on Thursday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. We made two trades: AMD, CVX Quick notes: AAPL, QCOM, HUM 1. Two trades: AMD, CVX Stocks turned mixed on Thursday … Read more

3 takeaways from Wednesday’s Investing Club ‘morning meeting’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Stocks are rising – for now, we’re fans of Starbucks’ incoming CEO. Quick Notes: LLY, MRVL, BHC 1. Stocks rise – … Read more

4 takeaways from Tuesday’s Investing Club ‘morning meeting’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments: Oscillator says market remains oversold. Our trading on DVN and CRM. Quick mentions: HON and LLY. View these stocks in great … Read more

We were mostly buyers during this turbulent week for stocks. Here is a summary of all our deals

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE After collecting money in recent weeks, we put money to work as the Fed-related selloff tipped the market into an oversold state. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We shop at this market, but also rarely do small sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Late Wednesday afternoon we will close a few more deals for the portfolio, with the net effect of putting more money to work. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

How we position our portfolio before the worst month of the year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’ve built our investments around companies that have historically been able to withstand tough environments and take advantage of recessions to buy high-quality technology. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

4 takeaways from Monday’s Investing Club ‘morning meeting’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a roundup of Monday’s key moments: Stocks slip to open week’s trading Oil falls after our Coterra Constellation dollar market sell-off warning Another Amazon healthcare move? 1. … Read more

4 takeaways from Monday’s Investing Club ‘morning meeting’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a roundup of Monday’s key moments: Falling oil is good news We want confirmation that inflation has peaked Quick mentions: JNJ, LLY, LIN Disney’s real problem is … Read more

We use the pullback of one of our drug stocks to buy more stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE While we are aware of the risk of liability, we continue to believe that this company’s exposure will be minimal, if any. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 takeaways from Monday’s Investing Club ‘morning meeting’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Nvidia warns of reset Bad news hasn’t destroyed the market De-inflation law could be bad for market 1 Nvidia warns of … Read more

Here are 5 stocks in our portfolio that can benefit from rising interest rates

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A strong labor market with big wage increases could mean the Fed has more work to do. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

AbbVie’s mixed quarter doesn’t warrant a 5% drop in shares. Here’s why

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE AbbVie hasn’t had quite the quarter, but Friday’s selloff is a bit puzzling. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We’re shorting 3 stocks that we still like after they’ve all rallied in recent weeks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Friday afternoon’s three sell-offs allow us to collect money as the stock market moves into overbought territory. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Bausch Health is sharing the tank in a worst-case scenario under a court order

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bausch Health said Thursday afternoon that it will “examine all available options to vigorously defend” its IP and the appeal. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Humana beats on earnings, leads higher. But profit takers are out after recent all-time highs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There may also be some disappointment that the guidance going forward was not stronger. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

13 of our companies report earnings this week. Here’s what Wall Street expects

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange (NYSE) on January 18, 2022 in New York City. The Dow Jones Industrial Average fell nearly 500 points in morning trading as investors weighed quarterly earnings and other economic news in a shortened trading week. Spencer Platt | … Read more

We’re adding to 2 stocks that posted strong gains but saw tepid market reactions

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The companies are also in two sectors that we think are right for this raw market: oil and healthcare. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Bargains in three stocks we like for the long term give us a chance to cut and cash in

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re taking advantage of Friday’s market rally and selling some stocks of companies we still like for the long term on strength. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We’re adding shares of a health-related company with a resilient revenue stream in tough times

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE With this stock around our full cost base, we want to take the opportunity to get some cash to work and increase our exposure. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We downgrade stocks we like that rise to fill some money for future market crashes

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Our sale of some shares is not an invitation to the health insurance company in question or our investment thesis. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We trim the winner we still believe in to raise some money and adjust our position

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We don’t want to be as greedy as we were with our oil names. We don’t want to make the same mistake twice. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Tuesday’s market bounce allows us to raise some money to buy in the next downturn

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We are collecting money that is about the same as the one we put to work last Friday in three deals when the market was much lower. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here are 5 Investing Club shares in the news and our view of what’s going on

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We break down five events involving our stocks, including Apple, Qualcomm and Eli Lilly. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

In the massacre of the market we buy the little things, we choose our paths to give money for work

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The club still believes a wide sell-off like Monday creates a long-term opportunity for stocks that don’t have much to do with current concerns. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Bausch Health shares are falling as the results of the recent IPO for eye care did not impress

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Although we do not directly own Bausch + Lomb shares, we do own shares in Bausch Health, which owns about 90% of its former eye care unit. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Eli Lilly’s new diabetes drug continues to be promising as an obesity treatment

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly continues to work on the commercialization of its strong innovation pipeline, which is the key reason CNBC Investing Club owns the stock. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We are changing the target prices for 8 shares in the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The shifts reflect recent earnings reports, comments from company executives and general market compression. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

On the decline, we add health insurance stocks, which had excellent earnings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This company got off to a good start this year, reporting a sharp drop in first-quarter profits and year-over-year outlook late last month. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We sell half of the retail economy to enter an undervalued health stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The high rating of our portfolio continued on Wednesday morning, with moves made at American Eagle Outfitters and Johnson & Johnson. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Investing Club: One of our big winners with the S&P 500 index is cut into a four-day winning streak

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We are now seeing a pretty good level in the whole market to start raising some money. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Investment Club: We take advantage of the amazing run of one of our drug stocks, we sell a few stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We will make more profit in AbbVie on Monday morning after the stock has achieved impressive growth recently. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Investment Club: We are buying into healthcare again, a sector isolated from geopolitical turmoil

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We like drug stocks and healthcare here because these are companies that can continue to grow earnings even if there is an economic slowdown. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Investment Club: Beyond the Bausch Mixed Quarter, we look at the greater value of disintegration

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The upcoming IPO of Bausch + Lomb and Solta Medical is crucial to realizing the earning power locked in a larger company. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

What the club is watching on Friday afternoon – including an example of Disney’s pricing ability

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Also on the list is what we believe Abbott is an excessive drop and a nice follow-up for Cisco. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

CNBC Investing Club: Bausch leaks details of one of its planned IPOs to unlock value

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As club members know, we are looking for these IPOs as a means of unlocking value by separating the three core business activities. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Cramer’s Investing Club: Buy Eli Lilly’s fall on drug delay news because it won’t matter in the long run

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The response of donanemab’s accelerated approval is seen only as speed. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Cramer’s Investing Club: We encourage you to gain AbbVie shares recently after a mixed quarter

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Despite some flawed results here and there, we saw strength in all the right places in AbbVie’s fourth-quarter earnings report. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source